II. Epidemiology
- Rare, but lethal Encephalitis (4 cases per year in U.S.)
III. Pathophysiology
- Naegleria Fowleri is a free living amoeba inhabiting free water and moist soils
- Exposure typically occurs with swimming in fresh water lakes, rivers or hot springs
- Transmitted via the nasal cavity and secondary Sinusitis, and CNS Infection via Cribiform Plate
IV. Findings
- See Meningitis
- See Encephalitis
V. Labs
-
CSF Exam is similar to Bacterial Meningitis findings
- High CSF White Blood Cell Count with Neutrophil predominance
- High CSF Protein
- Low CSF Glucose
-
CSF Microscopy
- CSF Gram Stain and Culture negative for Bacteria
- Motile amoeba may be seen on microscopy
VI. Differential Diagnosis
- See Meningitis
- See Encephalitis
-
Chronic Granulomatous Encephalitis (Acanthamoeba, Balamuthia mandrllaris)
- More insidious Encephalitis course
- Primarily in Immunocompromised patients
VII. Management
- Amphoteracin B 1.5 mg/kg/day (IV and consider intrathecal) AND
- Rifampin 10 mg/kg/day AND
- Fluconazole 10 mg/kg/day IV or orally AND
- Azithromycin 500 mg IV or orally AND
-
Miltefosine (Impavido) 50 mg orally three times daily
- As of 2017, investigational, and only available from CDC (consult early and urgently if suspected case)
VIII. Differential Diagnosis
- See Encephalitis
- See Meningitis
- Other amebic meningoencephalitis (present as Chronic Granulomatous Meningitis)
- Balamuthia mandrillaris
- Acanthameba
IX. Prognosis
- Mortality: 90-95% (typically in the first week of infection)
X. References
- Gladwin, Trattler and Mahan (2014) Clinical Microbiology, Medmaster, Fl, p. 339-40
- (2017) Sanford guide, accessed 5/4/2017
- Perkins (2017) Am Fam Physician 95(9): 554-60 [PubMed]